Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Luca Science, a Japan-headquartered developer of mitochondria-based therapeutics, completed a $9.8m series A round on Tuesday that included medical research equipment provider CaHC. The round was led by venture capital firm Axil Capital Partners and also featured Remiges Ventures, Nippon Venture Capital and Fast Track Initiative. The capital will be used to strengthen the company’s…

The rest of this content is only accessible to Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.